National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting
---
identifier: "/us/fr/2018-23033"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2018-23033"
section_name: "National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting"
positive_law: false
currency: "2018-10-23"
last_updated: "2018-10-23"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2018-23033"
document_type: "notice"
publication_date: "2018-10-23"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "83 FR 53491"
fr_volume: 83
---
# National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Diabetes, Endocrinology and Metabolic Diseases B Subcommittee, October 24, 2018, 05:30 p.m. to October 26, 2018, 04:00 p.m., Residence Inn Capital View, 2850 South Potomac Avenue, Arlington, VA, 22202 which was published in the *Federal Register* on September 12, 2018, 64 FR 46178.
The meeting is being amended to reflect location change. The new meeting location is the Renaissance Washington DC Downtown, 999 9th Street NW, Washington, DC 20001. The meeting is closed to the public.
Dated: October 17, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.